Market Overview
The pre-market on March 25, 2026 shows intense small-cap momentum, led by biotechnology and technology names with clinical news, earnings beats, and regulatory updates driving extreme volume and percentage gains. Low-float runners are attracting strong retail FOMO, with several stocks already up 15-80% pre-market on elevated participation.
Biotech and healthcare names stand out on FDA-related catalysts and financial results while select tech/holdings names print massive pre-market volume surges.
1️⃣ $ITOC (iTonic Holdings) | 🤖 Technology/Holdings
Current Status:
- Price: $0.513 (+80.11%)
- Float: 6.73M
- Volume: 64.04M (extremely high RVOL)
- Key Times: High 08:59 ET, Support test 08:50 ET
Trading Levels:
- Intraday Range: $0.47–$0.60
- Key Support: $0.47 (overnight), $0.50 (consolidation)
- Entry Zones: → $0.52 / $0.55
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $0.60 | T2 $0.70 | T3 $0.80 | T4 $0.90 | T5 $1.00
- Stop Loss: $0.48 (dynamic, max 3–5% risk)
- Trailing Stop: 10% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Top pre-market gainer, extreme % mover
- Volume: 64M shares, $33.9M dollar volume (extremely high RVOL)
- Indicators: RSI overbought, MACD bullish, above VWAP
- Pattern: Parabolic breakout (pre-market)
- Catalyst: Massive pre-market volume surge and momentum leadership – Scanner data March 25, 2026
2️⃣ $BZAI (Blaize Holdings) | 🤖 Technology
Current Status:
- Price: $1.60 (+44.14%)
- Float: 92.57M
- Volume: 15.32M (very high RVOL)
- Key Times: High 08:59 ET, Support test 08:55 ET
Trading Levels:
- Intraday Range: $1.53–$1.82
- Key Support: $1.53 (overnight), $1.60 (consolidation)
- Entry Zones: → $1.65 / $1.70
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $1.80 | T2 $2.00 | T3 $2.20 | T4 $2.40 | T5 $2.60
- Stop Loss: $1.52 (dynamic, max 3–5% risk)
- Trailing Stop: 8% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Top pre-market gainer
- Volume: 15.3M shares, $25.0M dollar volume (very high RVOL)
- Indicators: RSI strong, MACD bullish, above VWAP
- Pattern: Strong breakout (pre-market)
- Catalyst: Significant pre-market momentum and volume spike – Scanner data March 25, 2026
3️⃣ $QNRX (Quoin Pharmaceuticals) | 🧬 Biotechnology/Pharmaceuticals
Current Status:
- Price: $9.93 (+24.12%)
- Float: 1.57M
- Volume: 0.86M (high RVOL)
- Key Times: High 08:59 ET, Support test 08:45 ET
Trading Levels:
- Intraday Range: $8.62–$11.57
- Key Support: $8.62 (overnight), $9.50 (consolidation)
- Entry Zones: → $10.00 / $10.50
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $11.50 | T2 $12.50 | T3 $13.50 | T4 $15.00 | T5 $17.00
- Stop Loss: $9.20 (dynamic, max 3–5% risk)
- Trailing Stop: 7% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Top pre-market gainer, breakout
- Volume: 859K shares, $9.3M dollar volume (high RVOL)
- Indicators: RSI bullish, MACD crossover, above VWAP
- Pattern: Breakout on news (pre-market)
- Catalyst: Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome – TrendVision/Company release March 25, 2026
4️⃣ $MI (NFT) | 🤖 Technology
Current Status:
- Price: $0.348 (+22.20%)
- Float: 15.04M
- Volume: 42.80M (extremely high RVOL)
- Key Times: High 08:59 ET, Support test 08:50 ET
Trading Levels:
- Intraday Range: $0.31–$0.43
- Key Support: $0.31 (overnight), $0.34 (consolidation)
- Entry Zones: → $0.36 / $0.38
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $0.40 | T2 $0.45 | T3 $0.50 | T4 $0.55 | T5 $0.60
- Stop Loss: $0.32 (dynamic, max 3–5% risk)
- Trailing Stop: 10% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Top pre-market gainer, high volume
- Volume: 42.8M shares, $16.9M dollar volume (extremely high RVOL)
- Indicators: RSI strong, MACD bullish, above VWAP
- Pattern: Volume surge breakout (pre-market)
- Catalyst: Momentum leadership with massive pre-market volume – Scanner data March 25, 2026
5️⃣ $DXYZ (Destiny Tech) | 🤖 Technology
Current Status:
- Price: $32.19 (+21.38%)
- Float: 14.39M
- Volume: 2.43M (high RVOL)
- Key Times: High 08:59 ET, Support test 08:55 ET
Trading Levels:
- Intraday Range: $29.08–$35.54
- Key Support: $29.08 (overnight), $31.00 (consolidation)
- Entry Zones: → $32.50 / $33.50
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $35.00 | T2 $37.00 | T3 $39.00 | T4 $42.00 | T5 $45.00
- Stop Loss: $30.50 (dynamic, max 3–5% risk)
- Trailing Stop: 6% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Strong pre-market gainer
- Volume: 2.43M shares, $80.3M dollar volume (high RVOL)
- Indicators: RSI bullish, MACD positive, above VWAP
- Pattern: Continuation breakout (pre-market)
- Catalyst: High-volume momentum move – Scanner data March 25, 2026
6️⃣ $ENLV (Enlivex Therapeutics) | 🧬 Biotechnology
Current Status:
- Price: $1.32 (+20.00%)
- Float: 236.28M
- Volume: 0.87M (high RVOL)
- Key Times: High 08:59 ET, Support test 08:50 ET
Trading Levels:
- Intraday Range: $1.11–$1.35
- Key Support: $1.11 (overnight), $1.25 (consolidation)
- Entry Zones: → $1.35 / $1.40
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $1.50 | T2 $1.65 | T3 $1.80 | T4 $2.00 | T5 $2.20
- Stop Loss: $1.22 (dynamic, max 3–5% risk)
- Trailing Stop: 8% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Pre-market gainer with news
- Volume: 873K shares, $1.1M dollar volume (high RVOL)
- Indicators: RSI rising, MACD bullish, above VWAP
- Pattern: News-driven breakout (pre-market)
- Catalyst: Reports Full-Year 2025 Results with profit of $1.23 Billion and EPS of $25.48 – TrendVision/Company release March 25, 2026
7️⃣ $VNRX (VolitionRX) | 🧬 Biotechnology
Current Status:
- Price: $0.24 (+19.32%)
- Float: 126.68M
- Volume: 72.72M (extremely high RVOL)
- Key Times: High 08:59 ET, Support test 08:50 ET
Trading Levels:
- Intraday Range: $0.20–$0.29
- Key Support: $0.20 (overnight), $0.23 (consolidation)
- Entry Zones: → $0.25 / $0.26
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $0.28 | T2 $0.32 | T3 $0.35 | T4 $0.40 | T5 $0.45
- Stop Loss: $0.22 (dynamic, max 3–5% risk)
- Trailing Stop: 12% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Extreme volume mover
- Volume: 72.7M shares, $19.2M dollar volume (extremely high RVOL)
- Indicators: RSI strong, MACD bullish, above VWAP
- Pattern: High-volume breakout (pre-market)
- Catalyst: Announces Detection of Over 95% of Early-Stage Cancers – TrendVision/Company release March 25, 2026
8️⃣ $YYGH (YY Group Holding) | 🏗️ Industrials/Services
Current Status:
- Price: $1.24 (+14.91%)
- Float: 0.83M
- Volume: 2.65M (very high RVOL)
- Key Times: High 08:57 ET, Support test 08:40 ET
Trading Levels:
- Intraday Range: $1.05–$1.48
- Key Support: $1.05 (overnight), $1.15 (consolidation)
- Entry Zones: → $1.26 / $1.30
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $1.40 | T2 $1.55 | T3 $1.70 | T4 $1.85 | T5 $2.00
- Stop Loss: $1.15 (dynamic, max 3–5% risk)
- Trailing Stop: 8% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Breakout on news
- Volume: 2.65M shares, $3.8M dollar volume (very high RVOL)
- Indicators: RSI bullish, MACD positive, above VWAP
- Pattern: Breakout (pre-market)
- Catalyst: Announces Estimated Total Assets and Net Assets per Share for Fiscal Year 2025 – TrendVision/Company release March 25, 2026
9️⃣ $BURU (Nuburu) | 🏗️ Industrials
Current Status:
- Price: $0.206 (+15.01%)
- Float: 121.34M
- Volume: 37.98M (very high RVOL)
- Key Times: High 08:59 ET, Support test 08:50 ET
Trading Levels:
- Intraday Range: $0.18–$0.23
- Key Support: $0.18 (overnight), $0.20 (consolidation)
- Entry Zones: → $0.21 / $0.215
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $0.23 | T2 $0.25 | T3 $0.28 | T4 $0.32 | T5 $0.35
- Stop Loss: $0.19 (dynamic, max 3–5% risk)
- Trailing Stop: 10% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Multiple momentum/breakout alerts
- Volume: 38M shares, $7.95M dollar volume (very high RVOL)
- Indicators: RSI rising, MACD bullish, above VWAP
- Pattern: Momentum continuation (pre-market)
- Catalyst: Activates U.S. operations and multiple scanner hits – TrendVision/Company updates March 25, 2026
🔟 $NOTE (FiscalNote Holdings) | 🤖 Technology/Software
Current Status:
- Price: $0.81 (+15.20%)
- Float: 6.48M
- Volume: 2.56M (high RVOL)
- Key Times: High 08:52 ET, Support test 08:45 ET
Trading Levels:
- Intraday Range: $0.69–$0.94
- Key Support: $0.69 (overnight), $0.78 (consolidation)
- Entry Zones: → $0.82 / $0.85
Entry Confirmation:
- Require 2+ consecutive 1m/5m closes above the entry zone with reversal or volume surge.
- Do NOT enter on first touch without confirmation.
- Targets: T1 $0.90 | T2 $1.00 | T3 $1.10 | T4 $1.20 | T5 $1.35
- Stop Loss: $0.75 (dynamic, max 3–5% risk)
- Trailing Stop: 8% (5–15% scaled to volatility)
Technical Confirmation:
- Scanner Hits: Pre-market momentum
- Volume: 2.56M shares, $2.1M dollar volume (high RVOL)
- Indicators: RSI bullish, MACD positive, above VWAP
- Pattern: Breakout (pre-market)
- Catalyst: Launches PolicyNote MCP in OpenAI App Store expanding policy intelligence access – TrendVision/Company release March 25, 2026